Management of anti-D prophylaxis in RhD negative women undergoing early medical abortion – an international practice survey among practitioners
This study highlights the huge variations in anti-D prophylaxis practices during first trimester medical abortion. These discrepancies mirror differences in national and international guidelines and underscore the need for robust clinical evidence to determine the gestational age limits for alloimmunization risk and support protocol updates.
Authors
- Solenn Le Clanche (ORCID: https://orcid.org/0000-0003-1060-8397)
- Kristina Gemzell‐Danielsson (ORCID: https://orcid.org/0000-0001-6516-1444)
- Teresa Bombas (ORCID: https://orcid.org/0000-0003-2582-819X)
- L.A.W. Verhagen
- Aubert Agostini (ORCID: https://orcid.org/0000-0001-8171-1418)
- Alice‐Anaïs Varlet (ORCID: https://orcid.org/0000-0002-1670-4884)
- Marek Ľubušký (ORCID: https://orcid.org/0000-0003-0551-0942)
- Sharon Cameron (ORCID: https://orcid.org/0000-0002-1168-2276)
- Stephanie Kroeze (ORCID: https://orcid.org/0000-0002-1342-5310)
- Mirella Parachini
- Christian Fiala (ORCID: https://orcid.org/0000-0001-6451-7349)
- Myriam Chebbah (ORCID: https://orcid.org/0009-0004-7507-4386)
- Mary Favier
Institutions
- NHS Lothian (GB)
- Karolinska University Hospital (SE)
- Karolinska Institutet (SE)
- Doctors of the World (US)
- Nordic Pharma (Czechia) (CZ)
- Chalmers University of Technology (SE)
- Palacký University Olomouc (CZ)
- University of Coimbra (PT)
- University of Edinburgh (GB)
Publication Details
- Journal
- The European Journal of Contraception & Reproductive Health Care
- Published
- 2025-04-22
- DOI
- https://doi.org/10.1080/13625187.2025.2486690
- Citations
- 2
- Primary Topic
- Blood groups and transfusion
- Type
- article
- Field-Weighted Citation Impact
- 3.54